Novus Capital Limited is an investment and financial services company specialising in Investment Banking, Corporate Advisory and Share Trading services for Australian corporate and private clients, and overseas corporate clients.
Company Overview
EZZ Life Science Holdings Limited (‘EZZ’) is a leading genomic life sciences company with a mission to advance quality of life and human health by leveraging cutting-edge genomic research and innovative products to address key health challenges.
EZZ is at the forefront of delivering premium, science-backed health and wellness products, driven by a strong foundation in research and innovation. Through a dynamic omnichannel strategy spanning Australia, New Zealand, China and other global markets, the company is revolutionising access to and engagement with cutting-edge health solutions, enabling consumers to take control of their health and longevity.
Capital Structure
EZZ has 47,173,200 shares on issue as at 31 December 2025. The current market price of EZZ is approximately $2.25 per share, and the current market capitalization of EZZ is $110.86 million. The cash position of the Company as of 31 March 2025 is $21m.
Novus Role
In relation to Novus’ role to the Company, Novus’ role in detail would be to:
For more information please contact:
Naveed Hussain, Senior Client Adviser - Novus Capital Limited
Mobile +61 410 478 786 naveed.hussain@novuscapital.com.au